Stock Movers

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- JD Sports Fashion Plc cut its profit outlook after weaker-than-expected sales of sneakers in the second quarter, as its customers grapple with cost-of-living pressures and pull back on discretionary spending.
- Aegon shares fall as much as 4.5%, the worst drop since March, after the insurer released interim results. Analysts said operating capital generation and operating profit topped expectations, although mainly thanks to one-offs, and noted the stock’s strong performance leading into the print.
- Trainline drops a further 5.7% on Thursday, extending strong declines after Wednesday’s announcement of a UK competition watchdog investigation into so-called drip pricing, as JPMorgan cuts its price target to a new Street-low.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- JD Sports cut its profit outlook after weaker-than-expected sales of sneakers in the second quarter, as its customers grapple with cost-of-living pressures and pull back on discretionary spending.
- Novonesis jumped to a more than one-year high in Copenhagen trading after the world’s largest maker of industrial enzymes raised its financial forecast and said it will buy back own stock for the first time.
- Sartorius rises as much as 5.9%, the most in six weeks, after the stock was upgraded to buy from neutral at UBS. The German lab equipment maker is “well-positioned for accelerating growth” from 2027 to 2029, according to the broker.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- After SK Hynix unveiled its own program to buy back 40 trillion won ($29 billion) of stock, JPMorgan Chase & Co. said the company may follow that up with additional returns worth at least $130 billion. SK Hynix rose as much as 14.7%.
- Kuaishou Tech shares drop as much as 12% in Hong Kong after the Chinese Internet firm gave weak guidance for the coming quarter that triggered a wave of analyst downgrades over concerns around weak macro conditions and policy tightening on online-streaming e-commerce.
- Sino Biopharmaceutical and Asian healthcare firms are rising on the back of a skin cancer vaccine trial breakthrough by Moderna and Merck.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market, a look at the notable movers:
On this episode of Stock Movers:

-Moderna (MRNA) shares surged, delivering a $5.5 billion blow to short sellers who had bet that the vaccine maker's slump would continue. The company's stock price soared 177% after it said its personalized cancer vaccine helped reduce the recurrence of melanoma in a late-stage trial. The jump generated paper losses of about $5.5 billion for short sellers, bringing mark-to-market losses to roughly $7.7 billion this year, according to data from S3 Partners LLC.

- SK Hynix (KS) unveiled plans to buy back 40 trillion won of shares and return more profits to investors, moving to stabilize its shares after they fell more than 50% in two months. The memory chipmaker will buy back as many as 24 million shares between Aug. 20 and Nov. 19 and cancel them, and raised its shareholder return pledge to more than 50% of cumulative free cash flow from 2025 to 2027. SK Hynix’s buyback plan is partly aimed at appeasing Korean retail investors who were upset by the company’s decision to issue new shares for its US listing, rather than through existing treasury stock, which diluted their local holdings.

- Estée Lauder (EL) shares jumped after its results beat estimates and ended a run of three straight declines in annual revenue. The company reported revenue of $3.6 billion in its fiscal fourth quarter and adjusted earnings per share of $0.39, which topped expectations. The company reaffirmed guidance for organic net sales growth and raised guidance on its adjusted operating margin, with analysts saying a steady recovery is underway.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Isabelle Lee, Carol Massar and Emily Graffeo

- Moderna (MRNA) shares surged, delivering a $5.5 billion blow to short sellers who had bet that the vaccine maker's slump would continue. The company's stock price soared 177% after it said its personalized cancer vaccine helped reduce the recurrence of melanoma in a late-stage trial. The jump generated paper losses of about $5.5 billion for short sellers, bringing mark-to-market losses to roughly $7.7 billion this year, according to data from S3 Partners LLC.

- Estée Lauder (EL) shares jumped after its results beat estimates and ended a run of three straight declines in annual revenue. The company reported revenue of $3.6 billion in its fiscal fourth quarter and adjusted earnings per share of $0.39, which topped expectations. The company reaffirmed guidance for organic net sales growth and raised guidance on its adjusted operating margin, with analysts saying a steady recovery is underway.

- TJ Maxx (TJX) shares fall 0.84% in Wednesday trading after the clothing retailer reported second-quarter comparable sales for its Marmaxx segment, which includes TJ Maxx and Marshalls, that missed the average analyst estimate.
See omnystudio.com/listener for privacy information.